Activated Charcoal Use in Chronic Kidney Disease Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder

Interventions

DRUG

Activated Charcoal

oral activated charcoal capsules

DRUG

Phosphate Binders

calcium-based or non-calcium based (sevelamer) binders

Trial Locations (1)

RECRUITING

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors

lead

Mansoura University

OTHER

NCT06906874 - Activated Charcoal Use in Chronic Kidney Disease Patients | Biotech Hunter | Biotech Hunter